Frontiers in Pharmacology | Pharmacology of Anti-Cancer Drugs

Original Research

Published on 23 Jun 2023

Comprehensively analysis of immunophenotyping signature in triple-negative breast cancer patients based on machine learning

in Pharmacology of Anti-Cancer Drugs

Lijuan Tang
Zhe Zhang
Jun Fan
Jing Xu
Jiashen Xiong
Lu Tang
Yan Jiang
Shu Zhang
Gang Zhang
Wentian Luo

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1195864

3,975 views
7 citations

Review

Published on 23 Jun 2023

Update on poly(ADP-ribose) polymerase inhibitors resistance in ovarian cancer

in Pharmacology of Anti-Cancer Drugs

Ruihong Dong
Ting Ding
Zhengyu Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1164395

3,808 views
7 citations

Correction

Published on 23 Jun 2023

Corrigendum: Acute osimertinib exposure induces electrocardiac changes by synchronously inhibiting the currents of cardiac ion channels

in Pharmacology of Anti-Cancer Drugs

Peiwen Li
Xiaohui Tian
Gongxin Wang
Enshe Jiang
Yanming Li
Guoliang Hao

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1242042

1,331 views

Original Research

Published on 22 Jun 2023

ACSM6 overexpression indicates a non-inflammatory tumor microenvironment and predicts treatment response in bladder cancer: results from multiple real-world cohorts

in Pharmacology of Anti-Cancer Drugs

Zhiwei Li
Yiyan Yao
Tiezheng Qi
Zuowei Wu
Dingshan Deng
Bolong Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1222512

2,524 views
1 citation

Systematic Review

Published on 22 Jun 2023

Efficacy and safety of trastuzumab deruxtecan in the treatment of HER2-low/positive advanced breast cancer: a single-arm meta-analysis

in Pharmacology of Anti-Cancer Drugs

Zongyu Li
Shangwen Guo
Haoyi Xue
Luying Li
Yuyuan Guo
Sinuo Duan
He Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1183514

8,094 views
14 citations

Review

Published on 22 Jun 2023

Aortic dissection induced by vascular endothelial growth factor inhibitors

in Pharmacology of Anti-Cancer Drugs

Shuqi Dai
Yu Zhong
Hongxia Cui
Jin Zhao
Su Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1189910

4,495 views
10 citations

Review

Published on 21 Jun 2023

Potential role of gut microbes in the efficacy and toxicity of immune checkpoints inhibitors

in Pharmacology of Anti-Cancer Drugs

Jingxin Ma
Qi Wei
Xin Cheng
Jie Zhang
Zhongtao Zhang
Jianrong Su

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1170591

3,108 views
3 citations

Editorial

Published on 21 Jun 2023

Editorial: The roles of immune cell homeostasis in cancer research and therapeutic response

in Pharmacology of Anti-Cancer Drugs

Kui Zhang
Abhimanyu Thakur
Zhijie Xu
Zhi-Yao He

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1227996

1,629 views
1 citation

Review

Published on 20 Jun 2023

Pharmacological effects and mechanisms of paeonol on antitumor and prevention of side effects of cancer therapy

in Pharmacology of Anti-Cancer Drugs

Xindi Chang
Xiaoteng Feng
Min Du
Sijin Li
Jiarou Wang
Yiru Wang
Ping Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1194861

5,657 views
20 citations

Systematic Review

Published on 20 Jun 2023

Effectiveness and safety of anti-BCMA chimeric antigen receptor T-cell treatment in relapsed/refractory multiple myeloma: a comprehensive review and meta-analysis of prospective clinical trials

in Pharmacology of Anti-Cancer Drugs

Dingyuan Hu
Liming Chen
Diqin Yan
Wenliang Dong
Min Chen
Suping Niu
Simin Wang
Jiaojiao Zhang
Xiaoyan Nie
Yi Fang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1149138

6,827 views
13 citations

Original Research

Published on 20 Jun 2023

Deciphering the role of NETosis-related signatures in the prognosis and immunotherapy of soft-tissue sarcoma using machine learning

in Pharmacology of Anti-Cancer Drugs

Lin Qi
Fangyue Chen
Lu Wang
Zhimin Yang
Wenchao Zhang
Zhihong Li

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1217488

5,877 views
13 citations

Systematic Review

Published on 20 Jun 2023

Tislelizumab plus chemotherapy versus pembrolizumab plus chemotherapy for the first-line treatment of advanced non-small cell lung cancer: systematic review and indirect comparison of randomized trials

in Pharmacology of Anti-Cancer Drugs

Yimeng Guo
Junting Jia
Zhiying Hao
Jing Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1172969

6,770 views
9 citations

Editorial

Published on 19 Jun 2023

Editorial: Natural products modulate the sensitivity of cancer to anti-PD-1 based immunotherapy

in Pharmacology of Anti-Cancer Drugs

Jean Christopher Chamcheu
Qian Ba
Hang Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1232456

2,538 views

Editorial

Published on 19 Jun 2023

Editorial: Targeting oxidative stress in cancer: what is new in the prevention, diagnostic, treatment and prognostic strategies?

in Pharmacology of Anti-Cancer Drugs

Qianjin Liao
ZhiBin Wang
Silvia Maria Suter Correia Cadena

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1229785

2,245 views
2 citations

Case Report

Published on 16 Jun 2023

BCR-ABL1-positive acute lymphoblastic leukemia following successful treatment of acute promyelocytic leukemia: case report

in Pharmacology of Anti-Cancer Drugs

Shuang Fu
Mengqi Li
Hongtao Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1141311

2,590 views
1 citation

Original Research

Published on 15 Jun 2023

Lanatoside C decelerates proliferation and induces apoptosis through inhibition of STAT3 and ROS-mediated mitochondrial membrane potential transformation in cholangiocarcinoma

in Pharmacology of Anti-Cancer Drugs

Chao Zhang
Hong-Ying Yang
Long Gao
Ming-Zhen Bai
Wen-Kang Fu
Chong-Fei Huang
Ning-Ning Mi
Hai-Dong Ma
Ya-Wen Lu
Ning-Zu Jiang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1098915

4,947 views
12 citations